腹腔镜子宫腺肌病病灶切除术后的症状性复发危险因素:3年随访
回顾性研究纳入149例腹腔镜子宫腺肌病病灶切除术患者,其中症状性复发52例、无复发97例。Cox模型显示合并卵巢子宫内膜异位囊肿是复发的危险因素(HR 2.06),术后激素抑制(HR 0.30)和手术年龄≥40岁(HR 0.46)是保护因素。
要点
- 合并卵巢子宫内膜异位囊肿是术后症状性复发的危险因素(HR 2.06,95%CI 1.10-3.85)。
- 术后激素抑制可降低复发风险(HR 0.30,95%CI 0.16-0.55)。
- 手术年龄≥40岁较<40岁复发风险更低(HR 0.46,95%CI 0.24-0.88)。
核心结论
- 合并卵巢子宫内膜异位囊肿是腹腔镜子宫腺肌病病灶切除术后症状性复发的危险因素。
- 术后激素抑制和手术时年龄≥40岁是保护因素。
研究设计与样本
- 回顾性研究,大学附属医院,共纳入149例患者,其中症状性复发52例、无复发97例,随访3年。
主要发现
- 复发组与无复发组在手术年龄(p=.026)、合并卵巢子宫内膜异位囊肿(p<.001)和术后激素抑制处方(p<.0001)方面存在显著差异。
- 合并卵巢子宫内膜异位囊肿是复发的显著危险因素(HR 2.06;95%CI 1.10-3.85,p=.001)。
- 接受术后激素抑制者复发风险低于未接受者(HR 0.30;95%CI 0.16-0.55,p<.0001)。
- 年龄≥40岁者症状性复发风险低于<40岁者(HR 0.46;95%CI 0.24-0.88,p=.03)。
关键数值与推荐
- 合并卵巢子宫内膜异位囊肿:HR 2.06(95%CI 1.10-3.85,p=.001)。
- 术后激素抑制:HR 0.30(95%CI 0.16-0.55,p<.0001)。
- 手术年龄≥40岁 vs <40岁:HR 0.46(95%CI 0.24-0.88,p=.03)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To identify the clinical risk factors for symptomatic recurrence of adenomyosis after laparoscopic adenomyomectomy with a three-year follow-up. DESIGN: Retrospective study. SETTING: University-affiliated hospital. PATIENTS: A total of 149 patients were included in this study, including 52 patients with symptomatic recurrence and 97 without recurrence. INTERVENTION: Laparoscopic adenomyomectomy was performed first. MEASUREMENTS AND MAIN RESULTS: General clinical data, including preoperative, intraoperative, and postoperative indices, symptomatic recurrence, and follow-up information, were collected. Comparison of women with and without symptomatic recurrence revealed significant differences for age at surgery (p = .026), presence of concomitant ovarian endometrioma (p <.001), and prescription of postoperative hormonal suppression (yes/no) (p <.0001). A Cox proportional hazard model indicated that concomitant ovarian endometrioma was a significant risk factor for recurrence (hazard ratio [HR], 2.06; 95% confidence interval [CI], 1.10-3.85, p = .001). Patients who received postoperative hormonal suppression had a lower risk of recurrence than those without hormonal suppression (HR, 0.30; 95% CI, 0.16-0.55, p <.0001). Those aged ≥40 years also had a lower risk of symptomatic recurrence than those <40 years (HR, 0.46; 95% CI, 0.24-0.88, p = .03). CONCLUSIONS: Concomitant ovarian endometrioma is a risk factor for symptomatic recurrence of adenomyosis after laparoscopic adenomyomectomy. Postoperative hormonal suppression and older age at surgery (≥40 years) are protective factors.
引用
- Sun F, Yu J, Pan Y, et al. Risk Factors for Symptomatic Recurrence after Laparoscopic Adenomyomectomy: A 3-Year Follow-up. J Minim Invasive Gynecol. 2023. PMID: 36889669. doi:10.1016/j.jmig.2023.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。